Study type: In vivo/preclinical · Status: Citation identity verified
A highly efficient hybrid chemical sequence ameliorates intestinal inflammation and mucosal barrier damage by neutralizing lipopolysaccharides and antagonizing the lipopolysaccharide-receptor interaction.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
Study scale: Not reported
Citation only: Open source record
Product or molecular entity relationships
- LL-37: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
Plain-language verified summary
Question
Not reported in the reviewed source.
Methods
Not reported in the reviewed source.
Scale or participants
Not reported in the reviewed source.
Key findings
Not reported in the reviewed source.
Limitations and uncertainty
Not reported in the reviewed source.
Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.